PDXモデルのヨーロッパ市場:企業概要・規模・シェア・成長・動向・予測(~2025年)

【英語タイトル】Europe PDX Models Market : Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Data Bridge Market Researchが出版した調査資料(DBMR810492)・商品コード:DBMR810492
・発行会社(調査会社):Data Bridge Market Research
・発行日:2018年7月
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:ヨーロッパ
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Web Access)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Corporate UserUSD3,200 ⇒換算¥361,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Data Bridgeが出版した本調査レポートでは、PDXモデルのヨーロッパ市場について調査・分析し、PDXモデルのヨーロッパ市場動向、市場予測、セグメント別分析、PDXモデル市場規模、関連企業分析などを含め以下の構成でお届けいたします。
【レポートの概要】

Europe PDX models market was valued at USD 26.95 million in 2017 and growing at a lucrative rate of CAGR in the assessment period. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.

The key market players for Europe PDX models market are listed below:

• Crown Bioscience Inc.
• The Jackson Laboratory
• Champion Oncology, Inc.
• Charles River
• Oncodesign
• Wuxi AppTec
• Horizon Discovery Group plc
• Pharmatest Services
• Hera Biolabs
• EPO Berlin-Buch GmbH
• Xentech
• Urolead
• Creative Animodel
• EUROPDX
• MI Bioresearch Inc
• Aragen Bioscience

The market is further segmented into:
• Type
• Tumor Type
• Application
• End User

The Europe PDX models market is segmented based on type into two notable segments; mice models and rat models. In 2018, mice models segment is valued to rule with the highest market share 2025.
The Europe PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.
The Europe PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.
The Europe PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.
Based on geography, the market is segmented into:
• Germany
• France
• U.K.
• Spain
• Italy
• Switzerland
• Netherlands
• Russia
• Turkey
• Belgium
• Rest of Europe
Covered in this report
The report covers the present scenario and the growth prospects of the Europe PDX models market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table Of Contents
1 Introduction 11
1.1 Objectives Of The Study 11
1.2 Market Definition 11
1.3 Overview Of Europe Pdx Models Market 11
1.4 Currency And Pricing 12
1.5 Limitation 12
1.6 Markets Covered 12
2 Market Segmentation 14
2.1 Markets Covered 14
2.2 Geographic Scope 15
2.3 Years Considered For The Study 15
2.4 Currency And Pricing 16
2.5 Research Methodology 17
2.6 Primary Interviews With Key Opinion Leaders 20
2.7 Secondary Sources 21
2.8 Assumptions 21
3 Market Overview 22
3.1 Drivers 24
3.1.1 Rising Number Of Pharmaceutical R&D Activities In Cancer Research 24
3.1.2 Pdx Models Offer Advantages As Compared With The Classic Approach 26
3.1.3 Rising Need For Personalized Medicine 27
3.1.4 Increasing Support For Cancer Research Activities From Government And Non-Government Organization 27
3.2 Restraints 28
3.2.1 High Cost Of Pdx Models 28
3.2.2 Strict Regulation With Respect To The Utilization Of Animal Models In Cancer Research 28
3.3 Opprtunities 29
3.3.1 Increasing Demand For Humanized Pdx Models 29
3.4 Challenges 30
3.4.1 Limitations Of Pdx Models 30
4 Executive Summary 31
5 Premium Insights 33
6 Europe Pdx Models Market, By Type 36
6.1 Overview 37
6.2 Mice Models 39
6.3 Rat Models 40
7 Europe Pdx Models Market, By Tumor Type 41
7.1 Overview 42
7.2 Gastrointestinal Tumor Models 44
7.3 Gynecological Tumor Models 45
7.4 Respiratory Tumor Models 46
7.5 Urological Tumor Models 47
7.6 Hematological Tumor Models 48
7.7 Others 49
8 Europe Pdx Models Market, By Application 50
8.1 Overview 51
8.2 Preclinical Drug Development And Oncology Research 53
8.3 Biomarker Analysis 54
9 Europe Pdx Models Market, By End User 55
9.1 Overview 56
9.2 Contract Research Organizations 58
9.3 Pharmaceutical And Biotechnology Companies 59
9.4 Academic And Research Institutions 60
10 Europe Pdx Models Market, By Geography 61
10.1 Europe 61
10.1.1 Germany 70
10.1.2 France 72
10.1.3 U.K. 74
10.1.4 Italy 76
10.1.5 Spain 78
10.1.6 Switzerland 80
10.1.7 Netherlands 82
10.1.8 Turkey 84
10.1.9 Belgium 86
10.1.10 Russia 88
10.1.11 Rest Of Europe 90
11 Europe Pdx Models Market, Company Landscape 91
11.1 Company Share Analysis: Europe 91
12 Company Profiles 92
12.1 Charles River 92
12.1.1 Company Overview 92
12.1.2 Revenue Analysis 92
12.1.3 Company Share Analysis 93
12.1.4 Product Portfolio 93
12.1.5 Recent Developments 93
12.2 Crown Bioscience Inc. (Subsidiary Of Jsr Corporation) 94
12.2.1 Company Overview 94
12.2.2 Geographic Presence 94
12.2.3 Company Share Analysis 95
12.2.4 Product Portfolio 95
12.2.5 Recent Developments 96
12.3 Champion Oncology, Inc 97
12.3.1 Company Overview 97
12.3.2 Revenue Analysis 97
12.3.3 Company Share Analysis 98
12.3.4 Product Portfolio 98
12.3.5 Recent Developments 98
12.4 Aragen Bioscience (Subsidiary Of Gvk Biosciences Private Limited) 99
12.4.1 Company Overview 99
12.4.2 Product Portfolio 99
12.4.3 Recent Developments 99
12.5 Creative Animodel 100
12.5.1 Company Overview 100
12.5.2 Product Portfolio 100
12.5.3 Recent Developments 100
12.6 Epo Berlin-Buch Gmbh 101
12.6.1 Company Overview 101
12.6.2 Product Portfolio 101
12.6.3 Recent Developments 101
12.7 Europdx 102
12.7.1 Company Overview 102
12.7.2 Geographical Presence 102
12.7.3 Product Portfolio 103
12.7.4 Recent Developments 103
12.8 Hera Biolabs 104
12.8.1 Company Overview 104
12.8.2 Product Portfolio 104
12.8.3 Recent Developments 104
12.9 Horizon Discovery Group Plc 105
12.9.1 Company Overview 105
12.9.2 Revenue Analysis 105
12.9.3 Product Portfolio 106
12.9.4 Recent Developments 106
12.10 Mi Bioresearch Inc 107
12.10.1 Company Overview 107
12.10.2 Product Portfolio 107
12.10.3 Recent Developments 107
12.11 Oncodesign 108
12.11.1 Company Overview 108
12.11.2 Revenue Analysis 108
12.11.3 Product Portfolio 109
12.11.4 Recent Developments 109
12.12 Pharmatest Services Ltd 110
12.12.1 Company Overview 110
12.12.2 Geographic Presence 110
12.12.3 Product Portfolio 111
12.12.4 Recent Developments 111
12.13 The Jackson Laboratory 112
12.13.1 Company Overview 112
12.13.2 Revenue Analysis 112
12.13.3 Product Portfolio 113
12.13.4 Recent Developments 113
12.14 Urolead 114
12.14.1 Company Overview 114
12.14.2 Product Portfolio 114
12.14.3 Recent Developments 114
12.15 Wuxi Apptec 115
12.15.1 Company Overview 115
12.15.2 Geographic Presence 115
12.15.3 Product Portfolio 116
12.15.4 Recent Developments 116
12.16 Xentech 117
12.16.1 Company Overview 117
12.16.2 Product Portfolio 117
12.16.3 Recent Developments 117
13 Related Reports 118

List Of Tables
Uu
Table 1 Europe Pdx Models Market, By Type, 2016– 2025, (Usd Million) 38
Table 2 Europe Mice Models In Pdx Models Market, By Region, 2016-2025, (Usd Million) 39
Table 3 Europe Rat Models In Pdx Models Market, By Region, 2016-2025, (Usd Million) 40
Table 4 Europe Pdx Models Market, By Tumor Type, 2016– 2025 (Usd Million) 43
Table 5 Europe Gastrointestinal Tumor Models Market, By Region, 2016-2025, (Usd Million) 44
Table 6 Europe Gynecological Tumor Models Market, By Region, 2016-2025, (Usd Million) 45
Table 7 Europe Respiratory Tumor Models Market, By Region, 2016-2025, (Usd Million) 46
Table 8 Europe Urological Tumor Models Market, By Region, 2016-2025, (Usd Million) 47
Table 9 Europe Hematological Tumor Models Market, By Region, 2016-2025, (Usd Million) 48
Table 10 Europe Others Tumor Types In Pdx Models Market, By Region, 2016-2025, (Usd Million) 49
Table 11 Europe Pdx Models Market, By Application, 2016– 2025 (Usd Million) 52
Table 12 Europe Preclinical Drug Development And Oncology Research In Pdx Models Market, By Region, 2016-2025, (Usd Million) 53
Table 13 Europe Biomarker Analysis In Pdx Models Market, By Region, 2016-2025, (Usd Million) 54
Table 14 Europe Pdx Models Market, By End User, 2016– 2025, (Usd Million) 57
Table 15 Europe Contract Research Organizations In Pdx Model Market, By Region, 2016-2025, (Usd Million) 58
Table 16 Europe Pharmaceutical And Biotechnology Companies In Pdx Models Market, By Region, 2016-2025, (Usd Million) 59
Table 17 Europe Academic And Research Institutions In Pdx Modela Market, By Region, 2016-2025, (Usd Million) 60
Table 18 Europe Pdx Models Market, By Country , 2016 – 2025 (Usd Million) 67
Table 19 Europe Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 68
Table 20 Europe Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 68
Table 21 Europe Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 69
Table 22 Europe Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 69
Table 23 Germany Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 70
Table 24 Germany Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 70
Table 25 Germany Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 71
Table 26 Germany Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 71
Table 27 France Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 72
Table 28 France Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 72
Table 29 France Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 73
Table 30 France Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 73
Table 31 U.K. Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 74
Table 32 U.K. Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 74
Table 33 U.K. Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 75
Table 34 U.K. Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 75
Table 35 Italy Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 76
Table 36 Italy Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 76
Table 37 Italy Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 77
Table 38 Italy Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 77
Table 39 Spain Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 78
Table 40 Spain Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 78
Table 41 Spain Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 79
Table 42 Spain Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 79
Table 43 Switzerland Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 80
Table 44 Switzerland Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 80
Table 45 Switzerland Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 81
Table 46 Switzerland Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 81
Table 47 Netherlands Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 82
Table 48 Netherlands Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 82
Table 49 Netherlands Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 83
Table 50 Netherlands Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 83
Table 51 Turkey Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 84
Table 52 Turkey Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 84
Table 53 Turkey Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 85
Table 54 Turkey Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 85
Table 55 Belgium Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 86
Table 56 Belgium Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 86
Table 57 Belgium Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 87
Table 58 Belgium Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 87
Table 59 Russia Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 88
Table 60 Russia Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 88
Table 61 Russia Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 89
Table 62 Russia Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 89
Table 63 Rest Of Europe Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 90



【レポートのキーワード】

PDXモデル

★調査レポート[PDXモデルのヨーロッパ市場:企業概要・規模・シェア・成長・動向・予測(~2025年)] (コード:DBMR810492)販売に関する免責事項を必ずご確認ください。
★調査レポート[PDXモデルのヨーロッパ市場:企業概要・規模・シェア・成長・動向・予測(~2025年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆